Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event

INTRODUCTION: In the USA, patients with chronic heart failure (HF) with reduced ejection fraction (HFrEF) following a worsening HF event (WHFE) have significantly increased healthcare resource use and medical costs. This analysis aimed to estimate the budget impact of vericiguat as an add-on therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsumali, Adnan, Lautsch, Dominik, Liu, Rongzhe, Patel, Dipen, Nanji, Sakina, Djatche, Laurence M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107071/
https://www.ncbi.nlm.nih.gov/pubmed/33860924
http://dx.doi.org/10.1007/s12325-021-01681-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107071/
https://www.ncbi.nlm.nih.gov/pubmed/33860924
http://dx.doi.org/10.1007/s12325-021-01681-2

Ejemplares similares